Dexcom (NSDQ:DXCM) shares took a big jump up today on fourth-quarter results that topped the consensus forecast with relative ease and improved upon losses from the company’s previous fourth quarter. Shares of DXCM were up 13.8% at $286.96 per share in late-morning trading today. The San Diego–based continuous glucose monitor maker posted profits of $92.7 million, […]
Baxter probe finds $276 million in overstated income
Baxter (NYSE:BAX) says its income for the past four years may have been overstated by $276 million. The Deerfield, Ill.–based healthcare products company said the figures came out of a previously announced internal probe into its foreign exchange trading practices. That investigation is now substantially complete, the company said in an SEC filing yesterday. Baxter said […]
InVivo Therapeutics stock down after reverse stock split
InVivo Therapeutics’ (NSDQ:NVIV) recently announced 1-for-30 reverse stock split went into effect last night, and shares have taken a hit today as a result. NVIV was down -10.2% at $6.95 per share in midday trading today. Cambridge, Mass.–based spinal cord injury treatment developer initially announced the common stock split earlier this month, sharing that every 30 […]
Myomo shares down on news of $15m public offering
Shares of Myomo (NYSE:MYO) took a dive in price today after the commercial-stage medical robotics company announced it would raise $15 million from a public offering. MYO shares were down nearly 45% to $6.46 apiece by the afternoon. The company — maker of the MyoPro upper limb orthosis — is selling more than 2.1 million shares […]
Invacare posts losses, but sees stock rise
Despite fourth-quarter results that missed Wall Street projections and signaled increased losses, Invacare (NYSE:IVC) shares saw a sizeable bump on the markets today amid predictions of modest 2020 sales growth. IVC Shares were up 14.5% at $8.67 per share in mid-afternoon trading. The Elyria, Ohio-based company posted losses of -$18.7 million, or -56¢ per share, on […]
LeMaitre Vascular takes a big hit on 4Q slide
LeMaitre Vascular (NSDQ:LMAT) shares plummetted today on fourth-quarter results that came up shy of the consensus forecast and revealed a big dip in profits. The Burlington, Mass.–based maker of peripheral vascular disease devices posted profits of $4.6 million, or 23¢ per share, on sales of $30.2 million for the three months ended Dec. 31, 2019, for […]
Natus Medical stock takes a hit amid lower 2020 outlook
Natus Medical (NSDQ:NTUS) shares dipped today after the company lowered its 2020 sales guidance — even as it reported Q4 results met or slightly beat The Street. The Pleasanton, Calif.-based maker of monitoring and diagnostics for newborns posted profits of $3.2 million, or 10¢ per share, on sales of $131.8 million for the three months ended […]
Protolabs shares fall on Q4 results
Shares in Protolabs (NYSE: PRLB) dropped by 12.4% today on news of weak fourth-quarter demand. Sales met analysts’ expectations, but profits fell sharply compared with the fourth quarter of 2018. The Maple Plain, Minn.-based rapid manufacturing company reported profits of $15.19 million or $0.63 per share, on sales of $111.89 million for the three months ended Dec. 31, […]
Myomo stock sees week of volatility
Investors have traded millions of shares in commercial-stage medical robotics company Myomo (NYSE:MYO) this week, with the company saying it is unaware of what is causing the trading volatility. The Cambridge, Mass.–based company on Jan. 30 enacted a 1-for-30 reverse stock split, with stocks slumping for a few days before doubling in value on Tuesday and then […]
BD plummets on Q1 results as it cuts 2020 outlook
Becton Dickinson (NYSE:BDX) shares are down more than 10% today after the medtech giant lowered its guidance for the year amid ongoing problems with its Alaris infusion pump. The Franklin Lakes, N.J.-based company posted profits of $240 million, or 87¢ per share, on sales of $4.23 billion for the three months ended Dec. 31, 2019, for […]
Abiomed beats on earnings, misses on revenue in Q3 results
Abiomed (NSDQ:ABMD) posted third-quarter results that beat the earnings consensus on Wall Street, but missed on revenue. The Danvers, Mass.-based company reported profits of $69.2 million, or $1.51 per share, on sales of $221.6 million for the three months ended Dec. 31, 2019, for a bottom-line gain of 54.3% sales growth of 10.5% compared with Q3 […]
- 1
- 2
- 3
- …
- 561
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube